Developer docs
API playgroundTry for free, no card

Search company profiles

NJF Capital

Full company profile

uuid003cdrf

Namestring
NJF Capital
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
venture capital investing, growth equity funding, technology investments, life sciences investing, sports technology funding
Industry3 codes
1Sector-Focused Venture Capital (Vertical Specialists)
CodeFSANAAADPrimaryYes
2Early-Stage Venture Capital (Series A/B)
CodeFSANAAABPrimaryNo
3Geography-Focused Venture Capital (Regional/Emerging Markets)
CodeFSANAAAEPrimaryNo
NAICS code2 codes
  • All Other Financial Investment Activities52399
  • Portfolio Management and Investment Advice523940
SIC code2 codes
  • Investors, Nec6799
  • Investment Advice6282
Product category
Venture Capital / Private Equity
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Returns
TypeSubscription Recurring
Description

NJF Capital generates returns through equity investments in portfolio companies, realizing gains via exits, IPOs, or trade sales. As a venture investor, returns are long-dated, capital-intensive, and dependent on portfolio company growth and exit multiples.

tribuneindia.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

NJF Capital is the venture capital arm of NJF Holdings, deploying growth equity into early-to-growth-stage technology and life sciences companies. The firm targets opportunities at the convergence of professional sport, human performance, and life sciences — including sports performance technology firms, health technology platforms, diagnostics companies, and wearable technology providers — with a strategic focus on India as an emerging market for this intersection.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

NJF Capital is the venture capital arm of NJF Holdings, a global investment group founded by Nicole Junkermann. The firm operates as a platform comprising multiple investment verticals: NJF Capital serves as the core venture capital vehicle with a portfolio of more than 40 technology and life sciences companies; Gameday by NJF Holdings provides specialized sports infrastructure investment expertise; and The Human Code represents the firm's ethical investment philosophy emphasizing responsible innovation. The firm evaluates opportunities across sports performance technology, health technology platforms, diagnostics, wearables, and research partnerships, with particular focus on the convergence of professional sport, human performance, and life sciences in markets like India.

Product and service2 records
1NJF Capital Venture Capital Investment
CategoryVenture capital / growth equity investment
Description

Equity capital investment service for early-to-growth-stage technology and life sciences companies at the convergence of professional sport, human performance, and life sciences. The firm has built a portfolio of more than 40 companies across sports performance technology, health technology platforms, diagnostics, wearables, and research partnerships between professional leagues and life sciences institutions.

2Gameday by NJF Holdings
CategorySports infrastructure investment
Description

Sports infrastructure investment expertise arm under NJF Holdings, focused on providing investment capabilities in professional sports infrastructure and the convergence of professional sport, human performance, and life sciences. Complements NJF Capital's venture investing by covering sports infrastructure projects alongside early-stage technology investments.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-02
Description

Gameday by NJF Holdings is an affiliated entity providing sports infrastructure investment expertise within the NJF Holdings ecosystem. Together with NJF Capital (the venture arm), Gameday enables the group to pursue investment opportunities across the full spectrum of the sports and life sciences convergence — from early-stage technology companies to sports infrastructure projects — providing a differentiated and complementary capability set.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

A venture and growth fund focused on sports, entertainment, and human performance technology. Comparable to NJF Capital because both target the sports-tech convergence thesis, though Sapphire typically operates at later stages.

TypeBroad incumbent
Description

A large US venture firm with dedicated bio/health and emerging market practices. Comparable as a broad incumbent operating in adjacent verticals (health, life sciences, AI) that compete for the same founder pool as NJF Capital.

TypeDirect peer
Description

A venture capital firm running multiple vertical accelerator programs (including HAX for hardware and IndieBio for biotech). Comparable to NJF Capital as a sector-focused, vertical-specialist VC operating across health and life sciences adjacencies.

TypeRegional player
Description

An India-focused early-stage venture capital firm with deep exposure to technology and health-tech. Comparable to NJF Capital's India thesis, though broader in sector coverage.

TypeDirect peer
Description

An early-stage venture firm investing in sports, health, and consumer technology. Comparable to NJF Capital due to overlapping sports-tech and human-performance thesis at early stage.

TypeOthers
Description

A global venture studio and accelerator with dedicated sports and health programs. Comparable thematically as an ecosystem participant at the sports/health-tech intersection where NJF Capital invests, though operating as a builder rather than a pure investor.

TypeRegional player
Description

One of India's leading early-stage venture capital firms, investing across tech and health. Comparable to NJF Capital as an India-focused VC investor, though Blume operates as a generalist rather than sports-life sciences specialist.

TypeDirect peer
Description

A venture capital firm focused on early-stage investments at the intersection of sports, media, and technology. It is directly comparable to NJF Capital's sports-tech and human-performance focus, with a similar vertical specialization.

TypeBroad incumbent
Description

A leading India and Southeast Asia-focused venture and growth firm (formerly Sequoia Capital India). Comparable to NJF Capital as a major investor in India's technology and life sciences ecosystem, but operating at substantially larger scale and broader sector coverage.

TypeBroad incumbent
Description

A US-based venture firm with deep exposure to health, biotech, and India-impact investing. Comparable to NJF Capital's life sciences and India focus, though Khosla operates across many sectors and geographies at much larger scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment55 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NJF Capital

Venture Capital / Private Equitynjfcapital.com

NJF Capital firmographics

Firmographics
Name
NJF Capital
Website
https://njfcapital.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

NJF Capital industry classification

Industry
Product category
Venture Capital / Private Equity
NAICS
All Other Financial Investment Activities (52399), Portfolio Management and Investment Advice (523940)
SIC
Investors, Nec (6799), Investment Advice (6282)
akta.pro primary industry
Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
akta.pro secondary industries
Early-Stage Venture Capital (Series A/B) (FSANAAAB), Geography-Focused Venture Capital (Regional/Emerging Markets) (FSANAAAE)

Keywords

  • Venture capital investing
  • Growth equity funding
  • Technology investments
  • Life sciences investing
  • Sports technology funding

Where NJF Capital is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

NJF Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Venture Capital Returns: NJF Capital generates returns through equity investments in portfolio companies, realizing gains via exits, IPOs, or trade sales. As a venture investor, returns are long-dated, capital-intensive, and dependent on portfolio company growth and exit multiples.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

NJF Capital product offering

Product offering

Core offering

NJF Capital is the venture capital arm of NJF Holdings, deploying growth equity into early-to-growth-stage technology and life sciences companies. The firm targets opportunities at the convergence of professional sport, human performance, and life sciences — including sports performance technology firms, health technology platforms, diagnostics companies, and wearable technology providers — with a strategic focus on India as an emerging market for this intersection.

Product overview

NJF Capital is the venture capital arm of NJF Holdings, a global investment group founded by Nicole Junkermann. The firm operates as a platform comprising multiple investment verticals: NJF Capital serves as the core venture capital vehicle with a portfolio of more than 40 technology and life sciences companies; Gameday by NJF Holdings provides specialized sports infrastructure investment expertise; and The Human Code represents the firm's ethical investment philosophy emphasizing responsible innovation. The firm evaluates opportunities across sports performance technology, health technology platforms, diagnostics, wearables, and research partnerships, with particular focus on the convergence of professional sport, human performance, and life sciences in markets like India.

Differentiator

Problem solved

Functional benefit

Products and services

  • NJF Capital Venture Capital Investment Equity capital investment service for early-to-growth-stage technology and life sciences companies at the convergence of professional sport, human performance, and life sciences. The firm has built a portfolio of more than 40 companies across sports performance technology, health technology platforms, diagnostics, wearables, and research partnerships between professional leagues and life sciences institutions.
  • Gameday by NJF Holdings Sports infrastructure investment expertise arm under NJF Holdings, focused on providing investment capabilities in professional sports infrastructure and the convergence of professional sport, human performance, and life sciences. Complements NJF Capital's venture investing by covering sports infrastructure projects alongside early-stage technology investments.

Companies that use NJF Capital

Customer profile

Segments2 records

Ideal customer profiles2 records

NJF Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

NJF Capital partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Gameday by NJF HoldingscoreStrategic or Co-development Partner · 2 June 2026Gameday by NJF Holdings is an affiliated entity providing sports infrastructure investment expertise within the NJF Holdings ecosystem. Together with NJF Capital (the venture arm), Gameday enables the group to pursue investment opportunities across the full spectrum of the sports and life sciences convergence — from early-stage technology companies to sports infrastructure projects — providing a differentiated and complementary capability set.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

NJF Capital competitors and assessment

Company assessment

Direct peers

  • Sapphire Sport: A venture and growth fund focused on sports, entertainment, and human performance technology. Comparable to NJF Capital because both target the sports-tech convergence thesis, though Sapphire typically operates at later stages.
  • SOSV: A venture capital firm running multiple vertical accelerator programs (including HAX for hardware and IndieBio for biotech). Comparable to NJF Capital as a sector-focused, vertical-specialist VC operating across health and life sciences adjacencies.
  • Pendulum: An early-stage venture firm investing in sports, health, and consumer technology. Comparable to NJF Capital due to overlapping sports-tech and human-performance thesis at early stage.
  • Courtside Ventures: A venture capital firm focused on early-stage investments at the intersection of sports, media, and technology. It is directly comparable to NJF Capital's sports-tech and human-performance focus, with a similar vertical specialization.

Broad incumbents

  • Andreessen Horowitz: A large US venture firm with dedicated bio/health and emerging market practices. Comparable as a broad incumbent operating in adjacent verticals (health, life sciences, AI) that compete for the same founder pool as NJF Capital.
  • Peak XV Partners: A leading India and Southeast Asia-focused venture and growth firm (formerly Sequoia Capital India). Comparable to NJF Capital as a major investor in India's technology and life sciences ecosystem, but operating at substantially larger scale and broader sector coverage.
  • Khosla Ventures: A US-based venture firm with deep exposure to health, biotech, and India-impact investing. Comparable to NJF Capital's life sciences and India focus, though Khosla operates across many sectors and geographies at much larger scale.

Regional players

  • Kalaari Capital: An India-focused early-stage venture capital firm with deep exposure to technology and health-tech. Comparable to NJF Capital's India thesis, though broader in sector coverage.
  • Blume Ventures: One of India's leading early-stage venture capital firms, investing across tech and health. Comparable to NJF Capital as an India-focused VC investor, though Blume operates as a generalist rather than sports-life sciences specialist.

Others

  • Founders Factory: A global venture studio and accelerator with dedicated sports and health programs. Comparable thematically as an ecosystem participant at the sports/health-tech intersection where NJF Capital invests, though operating as a builder rather than a pure investor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

NJF Capital social profiles

Digital presence

NJF Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NJF Capital leadership team

Management profile

Number of profiles

Profiles3 records

NJF Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NJF Capital M&A and investment

M&A and investment

M&A

Investments55 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NJF Capital

What does NJF Capital do?

NJF Capital is the venture capital arm of NJF Holdings, deploying growth equity into early-to-growth-stage technology and life sciences companies. The firm targets opportunities at the convergence of professional sport, human performance, and life sciences — including sports performance technology firms, health technology platforms, diagnostics companies, and wearable technology providers — with a strategic focus on India as an emerging market for this intersection.

Is NJF Capital a public or private company?

NJF Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was NJF Capital founded?

NJF Capital was founded in 2015. It employs 1 to 10 people.

Where is NJF Capital based?

NJF Capital is headquartered in London, United Kingdom, in the Europe region.

How does NJF Capital make money?

One revenue line is on record: venture Capital Returns.

Who are NJF Capital's main competitors?

Direct peers on record are Sapphire Sport, SOSV, Pendulum and Courtside Ventures. Broad incumbents are Andreessen Horowitz, Peak XV Partners and Khosla Ventures. Regional players are Kalaari Capital and Blume Ventures. Founders Factory is listed as an others.

Does NJF Capital have an API?

No public API is recorded for NJF Capital.

What industry is NJF Capital in?

NJF Capital's product category is Venture Capital / Private Equity. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANAAAB, Early-Stage Venture Capital (Series A/B). Its NAICS code is 52399 and its SIC code is 6799.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The UpcomingHow Nicole Junkermann built an international investment platform across technology, healthcare and sportNicole Junkermann has established NJF Holdings, an investment platform founded in 2012 that operates across venture capital, private equity, and real assets with a focus on technology, healthcare, and sports. The portfolio includes NJF Capital for early-stage ventures in life sciences and AI, alongside Gameday by NJF Holdings which targets the infrastructure of sport and media. This cross-sector strategy aims to capitalize on long-term structural changes where scientific progress and technological capability intersect.CXOToday.comNicole Junkermann Outlines The Human Code for India’s AI Era and Responsible InnovationInternational investor Nicole Junkermann outlines The Human Code, an investment philosophy developed under NJF Holdings that emphasizes trust, ethics, human dignity, and long-term value creation as guiding principles for responsible AI development. The framework argues that while regulation is necessary for the AI age, it is insufficient without moral imagination and that capital allocation decisions should increasingly incorporate ethical due diligence alongside financial evaluation. The article positions India's rapid advancement in AI, digital infrastructure, and technology adoption as creating both significant opportunity and important questions around trust, responsibility, and inclusive growth.PR NewswireNJF Capital: The Rise of the Eurocorn: Europe's Billion-dollar BusinessesNJF Capital founder Nicole Junkermann discussed Europe's emergence as a major tech rival to the US, noting that 17 European companies achieved unicorn status in 2018, with the UK alone reaching 17 unicorns and ranking third globally behind the US and China. Junkermann attributes this boom to Europe's strong research base, startup-friendly regulations, and a growing M&A and consolidation culture that has particularly benefited Fintech and Medtech sectors. The article highlights NJF Capital's portfolio of potential unicorns, including UK-based cryptocurrency company Blockchain and French-American biotech firm Owkin, as examples of the high-quality opportunities emerging from Europe's intellectual infrastructure.PR NewswireSwarm Raises $25 Million Series A to Build World's Lowest-Cost Satellite NetworkSwarm Technologies, a Palo Alto-based satellite communications company, has closed a $25 million Series A funding round led by Craft Ventures and Sky Dayton, with participation from Social Capital, 4DX Ventures, and NJF Capital. The company plans to use the proceeds to accelerate software and hardware integrations for customer deployments, continue hiring, and deploy a constellation of 150 satellites over the next 18 months. Swarm has developed the world's smallest two-way communications satellites for low-cost, space-based IoT connectivity and already has seven operational satellites in Low Earth Orbit following a SpaceX Falcon 9 launch in December 2018.